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The protein kinase B (PKB/Akt), found in three distinctive isoforms (PKBα/Akt1,
PKBβ/Akt2, PKBγ/Akt3), is implicated in a variety of cellular processes such as cell
development, growth and survival. Although Akt3 is the most expressed isoform in the
brain, its role in cerebral functions is still unclear. In the present study, we investigated
the behavioral, electrophysiological and biochemical consequences of Akt3 deletion
in mice. Motor abilities, spatial navigation, recognition memory and LTP are intact
in the Akt3 knockout (KO) mice. However, the prepulse inhibition, three-chamber
social, forced swim, tail suspension, open field, elevated plus maze and light-dark
transition tests revealed an endophenotype reminiscent of psychiatric manifestations
such as schizophrenia, anxiety and depression. Biochemical investigations revealed
that Akt3 deletion was associated with reduced levels of phosphorylated GSK3α/β at
serine 21/9 in several brain regions, although Akt1 and Akt2 levels were unaffected.
Notably, chronic administration of lithium, a mood stabilizer, restored the decreased
phosphorylated GSK3α/β levels and rescued the depressive and anxiety-like behaviors
in the Akt3 KO mice. Collectively, our data suggest that Akt3 might be a critical molecule
underlying psychiatric-related behaviors in mice.
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INTRODUCTION
Psychiatric illnesses such as depression, bipolar disorders, anxiety and schizophrenia represent
an important public health problem causing not only personal suffering but also a tremendous
economic burden (Wittchen et al., 2011; Vigo et al., 2016). Over the recent years, many studies
have highlighted the role of genetic variations, abnormal neural development and dysregulation
of neurotransmitters to explain the development of these disorders (Renoir, 2014). Even if these
discoveries have led to a plethora of pharmacological treatments, their efficacy is still limited
(Gould and Einat, 2007; Duman and Voleti, 2012). Therefore, identification of key cell signaling
molecules and pathways are critical to uncover novel therapeutic targets and successful clinical
interventions.
A family of serine/threonine kinases, the protein kinase B (PKB/Akt), has received extensive
consideration in recent years for its possible involvement in psychiatric conditions. For instance,
Akt activity is known to be modified by antidepressants, antipsychotics and mood stabilizers
(Beaulieu et al., 2009). The Akt protein is constituted by three isoforms termed Akt1/PKBα,
Akt2/PKBβ and Akt3/PKBγ. Despite the fact that they are showing strong homologies, these
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isoforms are encoded by distinct genes (Diez et al., 2012). The
most abundant isoforms is Akt1. Akt1 is ubiquitously expressed
whereas Akt2 is primarily expressed in insulin-responsive tissues
and Akt3 is very much expressed in brain and testes (Hers et al.,
2011). Understanding brain Akt functions has been gained by
the generation of transgenic and knockout (KO) mouse models
(Yang et al., 2004; Dummler et al., 2006). For instance, a partial
lethality is observed in mice lacking Akt1 and the surviving
mice are reduced in size at birth and remain small throughout
life (Cho et al., 2001; Yang et al., 2003). Akt2 is particularly
important for glucose metabolism (Cho et al., 2001; Garofalo
et al., 2003) and a role in photoreceptor survival is observed
(Li et al., 2007). Recently, signs of anxiety and depressive-like
behaviors have been reported in mice lacking Akt2 (Leibrock
et al., 2013). The role of Akt3 is less clear even though it appears
to be themost highly expressed isoform in the brain.Mice lacking
Akt3 exhibit small brains (Easton et al., 2005; Poduri et al., 2012).
It is noteworthy that a multi-stage schizophrenia genome-wide
association study has identified Akt3 as a potential contributor to
schizophrenia, which underscore the importance of investigating
the role of Akt3 in the brain (Schizophrenia Working Group of
the Psychiatric Genomics Consortium, 2014).
The goal of the present study is to define the behavioral,
electrophysiological and biochemical consequences of
Akt3 deletion in mice. Our findings reveal that Akt3 deletion in
mice does not affect motor, cognitive and synaptic functions,
but is associated with behavioral abnormalities reminiscent of
psychiatric symptoms. Notably, the depressive and anxiety-like
behaviors are reversed by a chronic lithium treatment. Our data
provide evidence that Akt3 signaling may play a role in the
pathogenesis of psychiatric conditions.
MATERIALS AND METHODS
Animals
This study was carried out in accordance with the
recommendations of the UQTR Institutional Animal Care
and Use Committee and performed in accordance with the
Canadian Council on Animal Care. The generation of Akt3 KO
mice has been described previously (Easton et al., 2005). In all
experiments, 12–18 weeks-old Akt3 KO male mice (C57bl/6j
background) and their respective wild type (WT) littermates
were used. They were housed in groups of 3–4 per cage (12 h
light-dark cycles) with ad libitum food and water. Akt3 KO and
WT mice were genotyped by PCR analysis of DNA samples
obtained from ear punches. Five sets of experiments were
conducted on five independent cohorts of WT and Akt3 KO
mice. (1) One set of experiments involved behavioral testing
run from least to most invasive, to decrease the chance that
behavioral responses are altered by prior test. Morris water
maze, novel object recognition, elevated plus maze, light-dark
transition, three-chamber social test, forced swim test (FST) and
tail suspension test (TST) were performed in this sequence in
drug naïve WT and Akt3 KO mice. (2) Another set investigates,
in order, the rotarod, wire suspension, pole and stepping tests.
(3) The open field and prepulse inhibition tests were performed
at the Neurophenotyping Centre (Douglas Mental Health
Institute, Montreal, QC, Canada). (4) One set included drug
naïve WT and Akt KO mice exclusively for electrophysiology
experiments. Finally, (5) one set investigated the elevated plus
maze and FSTs in four groups of mice: WT-Standard chow,
WT-Lithium, Akt3 KO-Standard chow and Akt3 KO-Lithium.
Behavioral Tests
To perform comprehensive behavioral analyses of WT and
Akt3 KO mice, we used previously well-characterized tests
(Crawley, 2008). A period of 30 min of habituation in the
experimental room was allowed prior the test. All tests were
performed between 8 a.m to 4 p.m and were separated from each
other by 2 days at least.
Motor Ability Tests
General motor behavior of mice was evaluated using the rotarod,
the wire suspension, pole and stepping tests as we described
previously (Chagniel et al., 2014). First, mice were pre-trained
on the rotarod (AccuScan Instruments, Columbus, OH, USA)
five times at a constant rate of 10 rpm. A resting time of 180 s
was allowed between each trial. The end of a trial was considered
when mice were falling off the rod or when they reached 150 s.
The next day following the pre-training, mice performed the
rotarod three times at a constant rate of 10 rpm and latency to
fall was recorded for each trial. Briefly, the wire suspension test
consisted to hang the animal with its paws on themiddle of a wire
fixed horizontally between two platforms (length: 80 cm, height:
25 cm). The time needed to reach one platform was recorded.
For the pole test, mice were placed at the upper end of a pole
(length: 50 cm, diameter: 1.5 cm). The time taken to turn down
and reach the base of the pole was recorded. A maximum time
of 120 s was allowed to execute the wire suspension and pole
test. The stepping test consists to lift up the mouse’s hind legs by
pulling up the tail, leaving only the forepaws on the table. Then,
the experimenter pulled the animal backward by the tail (1 min
in 5–6 s), until the other edge of the table was reached. Each trial
was recorded using a video camera and the number of adjusting
steps for both forepaws was calculated.
Morris Water Maze
In a circular pool (122 cm of diameter) filled with opaque water
(23◦C), mice learning and memory was evaluated. For spatial
acquisition, mice were trained to reach the submerged platform
(12× 10 cm) four times per day for five consecutive days. Latency
to find the platform was measured. On the 6th day, a probe trial
was given. The platform was withdrawn from the pool and the
time of exploration in each quadrant was measured.
Novel Object Recognition
Mice were habituated 10 min in the test box (40 × 40 cm) for
three consecutive days. On day 4, two identical objects (dice)
were placed in the opposite corners of the box and mice were
allowed to explore for 10 min. Twenty-four hours later, one of
the familiar objects was replaced by a novel object (red ball) and
mice were left in the box exploring for 10 min. The session was
recorded using a video camera and exploration of the familiar
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or the novel object was evaluated. Exploration of the object was
considered when a mouse displayed any investigative behaviors
(head toward object, sniffing closely or entering an area within
1 cm around the object).
Prepulse Inhibition
Prepulse inhibition (PPI) was assessed in a sound-attenuated
chamber (8× 16 cm). The session beganwith a 5min acclimation
to a background noise of 70 dB. This is followed by a 10 trials
block of a 120 dB startle stimulus (without prepulse). Then,
to assess PPI, the startle stimulus was preceded by a 30 ms
prepulse stimulus. The intensity of the prepulse varied between
73 and 85 dB, in increment of 3 dB. Each intensity intervals were
presented five times and were randomly generated. The inter-
trial intervals were variable from 5 s to 30 s with an average of
15 s. Startle responses were collected every 1 ms for 100 ms after
startle stimulus and were averaged for each prepulse intensity.
Percentage of prepulse inhibition was calculated as: [(startle +
prepulse)/startle)× 100].
Three-Chamber Social Test
Mice were tested for social interactions using a three-chamber
box (20 × 40 cm, each chamber). First, the mouse was placed in
the central chamber and was allowed to explore the entire box
for a 5 min habituation session. In the session I, which evaluate
sociability, the mouse was given the choice to interact with either
an empty wired cage (9 cm of diameter, 11 cm height, placed in
one side chamber) or an unfamiliar mouse (stranger 1) placed in
a similar cage on the other side chamber. For 10 min, the tested
mouse was allowed to explore and the time spent exploring the
empty cage and the stranger I was recorded. In the session II,
which test the preference for social novelty, a second unfamiliar
mouse (stranger II) was placed in the empty chamber. The time
spent exploring the stranger I or the stranger II was recorded for
10 min.
Forced Swim Test
Mice were deposed individually into a transparent plastic
cylinder (20 cm height, 15 cm diameter), filled with water (11 cm
deep, kept at 25◦C). Immobility time (no limb movement) was
measured in the last 4 min of the 6 min recorded session.
Tail Suspension Test
Mice were suspended by the tip of the tail 35 cm to the ground
for a period of 6 min. Immobility time was measured on the last
4 min of the test. Mice were considered immobile when they
ceased struggling and remained motionless.
Open Field
Mice were placed 60min in a box (1× 1m) for habituation. After
habituation, the time spent in the central zone were recorded
and measured for 90 min with Versamax software (Accuscan
Instruments, Columbus, OH, USA).
Elevated Plus Maze
The elevated plus maze consisted in a cross-shaped platform
with two open and two closed arms, elevated 50 cm above the
floor. Mice were placed in the center of the maze facing one of
the closed arms. Mice were allowed to explore the cross-shaped
platform for 10 min. The number of entries as well as the time
spent in the open and closed arms were measured.
Light-Dark Transition
The apparatus consisted in a box (40 × 40 cm) divided into two
equal sections. One chamber was brightly illuminated, whereas
the other chamber was dark. Mice were placed into the dark area
and allowed tomove freely between the two chambers through an
open door for 10 min. The total number of transitions from the
dark to the light chamber and the time spent in the light chamber
were recorded.
Chronic Lithium Treatment
For chronic lithium treatment (LiCl), mice were placed on a 0.2%
LiCl diet (Harlan Teklab, Madison, WI, USA) for 5 days followed
by a 0.4% LiCl diet for an additional 20 days (O’Brien et al., 2004).
All mice received drinking water supplemented with 0.9% saline
to reduce ion imbalance caused by polyurea of lithium treatment.
Control group mice were fed with standard chow. Behavioral
experiments began on day 10. At day 26, mice were anesthetized
under isoflurane, decapitated and brains were immediately
removed. At the same time, blood was collected through a cardiac
puncture for lithium serum dosage. Lithium levels in the serum
samples were measured with a flame photometer (Perkin-Elmer,
model Analyst 100). The hippocampus, striatum, anterior cortex
and cerebellum were dissected rapidly and frozen on dry ice until
processed for western blot analysis.
Biochemical Analysis
WT and Akt3 KO mice were anesthetized under isoflurane,
decapitated and brains were immediately removed. The striatum,
hippocampus, cerebellum and anterior cortex were dissected,
frozen on dry ice and preserved at −80◦C. The western
blots were performed as previously described (Bergeron
et al., 2014). Antibodies used were raised against Akt1,
Akt2, Akt3, phosphorylated GSK3α/β at serine 21/9 (Cell
signaling, 1:1000), total GSK3α/β (Millipore, 1:2000) and
GAPDH (Abcam, MA, USA 1:20,000). Membranes were washed
and incubated with appropriate HRP-conjugated secondary
antibody (Cell signaling, 1:5000). To visualize protein bands,
chemiluminescence reactions were used (SuperSignal West
Femto chemiluminescence kit, Pierce Chemical Co, IL, USA).
Densitometry analysis was performed using the VisionWorks
LS software (UVP Bioimaging Upland, Upland, CA, USA) and
expressed as relative optical density.
Electrophysiology
Hippocampal slice preparation was performed as described
before (Laurier-Laurin et al., 2014). Briefly, WT and Akt3 KO
mice were anesthetized under isoflurane, decapitated and
hippocampi were dissected in an ice-cold cutting buffer.
Transverse slices (350 µm) were prepared with a McIlwain
tissue chopper and transferred in artificial cerebrospinal fluid.
The slices were allowed to recover 1 h before recordings.
A glass recording electrode (1–5 M filled with 2 M NaCl)
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was positioned in the stratum radiatum of area CA1 of the
hippocampus to record field excitatory postsynaptic potentials
(fEPSPs) evoked by a bipolar electrode (twisted 60 µm
nichrome), activating fibers of the Schaffer collateral system.
Stimulation consisted of a 0.1 ms pulse delivered every 30 s
(0.033 Hz) with current intensity adjusted to obtain 40%–50%
of maximal fEPSPs. After a 10 min baseline period, theta-
burst stimulations (10 bursts of four stimulation pulses at
100 Hz) were given at 200 ms (5 Hz) intervals. After this
block of tetanic stimulation, fEPSPs were again collected
at the baseline presentation rate (0.033 Hz). In all cases,
fEPSPs were recorded with NAC 2.0 software (Theta Burst
Corp., Irvine, CA, USA) and the response to stimulation was
quantified by calculating the initial amplitude of resulting
fEPSPs.
Statistical Analysis
Data were analyzed with GraphPad Prism software (version
5.0, Graph Pad Software, San Diego, CA, USA). Statistical
analysis were determined by unpaired Student’s t-test, two-way
repeated-measures analysis of variance (ANOVA) followed by
the Bonferroni post hoc test or by paired Student’s Wilcoxon
t-test. Data are shown as the mean ± SEM and statistical
significance was set at P < 0.05.
RESULTS
Levels of Akt Isoforms in the Akt3 KO
Mouse Brain
Akt protein levels were assessed by Western blot in the
anterior cortex, striatum, hippocampus and cerebellum. As
expected, Akt3 protein was undetectable in brain regions
examined in Akt3 KO mice (Figure 1A). To evaluate whether
Akt1 or Akt2 expression was affected by the Akt3 deletion, levels
of Akt1 and Akt2 were also measured. Compared to WT mice,
FIGURE 1 | Levels of Akt isoforms in the Akt3 knockout (KO) mouse
brain. (A) Levels of Akt1, Akt2 and Akt3 were assessed by western blot in the
anterior cortex, striatum, hippocampus and cerebellum. The data, expressed
relative to GAPDH, represent the mean of relative optical density of Akt1 and
Akt2 (expressed as a percentage of control values) ± SEM, n = 3–4; triplicate
experiments for each mouse/group. Since Akt3 protein was undetectable in
Akt3 KO mice, we did not quantify the optical density.
levels of Akt1 and Akt2 remained unchanged in Akt3 KO brain
structures considered (Figure 1A).
Normal Motor Abilities and Cognitive
Functions in Akt3 KO Mice
To verify the effect of Akt3 deletion on general motor abilities,
we performed well recognized motor tests: the rotarod, the
pole, wire suspension and stepping tests. No difference was
observed between Akt3 KO and WT performances in all
tests, revealing that Akt3 KO mice do not suffer from a
generalized deficit in locomotion, motor abilities and activity
levels (Figures 2A–D).
To study the impact of Akt3 deletion on cognitive functions,
we performed the Morris water maze and the novel object
recognition tests. After 5 days of training in the Morris water
maze, two-way repeated measures ANOVA followed by the
Bonferroni post hoc test revealed that Akt3 KO and WT mice
required similar time to find the hidden platform (genotype,
F(1,135) = 1.388; p > 0.05; days, F(4,135) = 23.36; p < 0.001;
genotype × days, F(4,135) = 0.2930; p > 0.05; Figure 2E). During
the probe test, Akt3 KO and WT mice spent more time in
the target quadrant compared to other quadrants (genotype,
F(1,108) = 0.02350; p> 0.05; quadrant, F(3,108) = 25.06; p< 0.001;
genotype × quadrant, F(3,108) = 0.2847; p > 0.05; Figure 2E).
In the novel object recognition test, two-way ANOVA followed
by the Bonferroni post hoc test revealed that both mice
groups explored preferentially the novel object rather than the
familiar object (genotype, F(1,38) = 0.4278; p > 0.05; objects,
F(1,38) = 23.12; p < 0.001; genotype × objects, F(1,38) = 1.254;
p> 0.05; Figure 2F).
Adjacent coronal brain slices containing the hippocampus
from Akt3 KO and WT mice were prepared for
electrophysiological experiments. Theta-burst stimulation
of the Schaffer commissural pathway in area CA1 of the
hippocampus was then used to elicit synaptic potentiation.
In the present investigation, evoked fEPSPs were statistically
compared immediately and 40 min after theta-burst stimulation
to determine the possible impact of Akt3 deletion on short-term
and long-term potentiation, respectively. We found that neither
short nor long-term potentiation was modified in Akt3 KO
mice compared to WT mice (paired Student’s Wilcoxon t-test,
p> 0.05; Figure 2G).
Akt3 KO Mice Exhibit an Endophenotype
Reminiscent of Psychiatric Conditions
Social behavior was evaluated by the three-chamber social test.
In the Session I, two-way ANOVA followed by the Bonferroni
post hoc test showed that Akt3 KO and WT mice explored
preferentially the cage with a stranger mouse than an empty
cage. Interestingly, Akt3 KO mice showed significantly lower
investigation time of stranger mouse than WT mice, reflecting
impaired social behavior (cage type, F(1,34) = 38.18; p < 0.001;
genotype, F(1,34) = 10.09; p < 0.01; cage type × genotype,
F(1,34) = 2.361; p > 0.05; Figure 3A). In the Session II,
the preference for social novelty was measured. WT mice
spent more time exploring the novel stranger mouse II than
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FIGURE 2 | Normal motor abilities and cognitive functions in Akt3 KO mice. Motor abilities on the (A) Rotarod, (B) Pole, (C) Wire and (D) stepping tests of
Akt3 KO and wild type (WT) mice were evaluated. Data represent the average mean latency to fall expressed in seconds from three assays (rotarod) ± SEM,
n = 7 mice/group. Data represent the mean time require to perform the test (pole and wire) and the mean numbers of adjusting steps (stepping) ± SEM,
n = 6–7 mice/group. (E) Mice were trained on the Morris water maze. Spatial acquisition is evaluated by the latency to reach the hidden platform at each day of
training expressed in seconds ± SEM, n = 12–17 mice/group. Memory is evaluated during the probe trial by the time spent in each quadrant expressed in
seconds ± SEM, n = 12–17 mice/group. ∗∗∗p < 0.001 vs. target quadrant. (F) The novel object recognition test was performed to evaluate memory. Time spent
exploring the familiar or the novel object is shown as a ratio of the total time spent exploring both objects ± SEM, n = 10–11 mouse/group. ∗p < 0.05,
∗∗∗p < 0.001 vs. familiar object. (G) Examples of average fEPSPs elicited in the stratum radiatum before and after theta-burst stimulation in WT and Akt3 KO slices.
Each sample trace is an average of five consecutive responses. Calibration bar: 5 ms; 1 mV. Amplitude of fEPSPs was measured before and after theta-burst
stimulation and fEPSPs were expressed as the percentage of the average response before theta-burst stimulation (arrow). The values obtained during the period
preceding theta-burst stimulation were averaged to derive baseline value. The data are expressed as percentages of baseline values and each point represents the
mean ± SEM, n = 7.
the familiar stranger mouse I, while Akt3 KO mice did not
show preference between stranger mouse I and II (cage type,
F(1,32) = 23.08; p< 0.05; genotype, F(1,32) = 6.829; p< 0.001; cage
type × genotype, F(1,32) = 5.362; p < 0.05; Figure 3A). The PPI
test was performed to evaluate sensorimotor gating. Two-way
ANOVA followed by the Bonferroni post hoc test revealed an
overall decrease in PPI responses in Akt3 KO mice compared
to WT mice (intensity, F(4,105) = 39.85; p < 0.001; genotype,
F(1,105) = 58.46; p < 0.001; intensity × genotype, F(4,105) = 1.609;
p> 0.05; Figure 3B).
We next examined depressive-like behaviors in mice. In the
forced swim and the TSTs, Akt3 KO mice spent more time
immobilized compared to WT mice (unpaired t-test, p < 0.001;
Figures 4A,B). Anxiety-related behaviors were also evaluated.
The open field test revealed that Akt3 KO mice were less active
(unpaired t-test, p < 0.001) and covered a shorter distance
in the central zone compared to WT mice (unpaired t-test,
p < 0.001; Figure 4C). The elevated plus maze showed that
Akt3 KO mice spent a lower proportion of time in the open
arms (unpaired t-test, p < 0.05) and entered less frequently in
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FIGURE 3 | Decreased social behaviors and impaired sensorimotor gating in Akt3 KO mice. Social behavior and social novelty were examined in the
three-chamber sociability test. (A) On session I, sociability was evaluated by the time Akt3 KO and WT mice were exploring the stranger mouse (stranger I) and the
empty cage. Data represent the mean time of exploration expressed in seconds ± SEM, n = 8–11 mice/group. ∗∗p < 0.01, ∗∗∗p < 0.001 vs. exploration of stranger
mouse I by WT mice; ##P < 0.01 vs. exploration of stranger mouse I by Akt3 KO. On session II, preference for social novelty was evaluated by comparing the time
mice explored the familiar stranger mouse I and the novel stranger mouse II. Data represent the mean exploration time expressed in seconds ± SEM,
n = 8–11 mice/group. ∗∗p < 0.01 vs. exploration of stranger mouse I by WT mice, ###p < 0.001 vs. exploration of stranger mouse II by WT mice. (B) Sensorimotor
gating was evaluated by measuring the level of prepulse inhibition for different prepulse intensities. Data represent the mean percentage ± SEM,
n = 11–12 mice/group. ∗∗P < 0.01, ∗∗∗P < 0.001 vs. WT mice.
FIGURE 4 | Depressive and anxiety-like behaviors in Akt3 KO mice. Depressive-like behaviors were evaluated by measuring the immobile time of Akt3 KO
mice and WT mice in (A) the forced swim test (FST) and (B) the tail suspension test (TST). (C) In the open field, anxiety-like behavior was based on mice activity and
distance traveled in the central zone. (D) In the elevated plus maze, time in open arms and number of entries in open arms were measured. (E) In the light-dark test,
time spent in the light chamber and number of entries in the light chamber was measured. All data are expressed as the mean ± SEM, n = 11–17 mice/group.
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. WT mice.
the open arms compared to WT mice (unpaired t-test, p < 0.01;
Figure 4D). Finally, we observed in the light-dark transition test
that Akt3 KO mice spent a lower proportion of time (unpaired
t-test, p < 0.01) and exhibited a lower number of transitions
in the lighted chamber compared to WT mice (unpaired t-test,
p< 0.05; Figure 4E).
Chronic Lithium Treatment Rescued
Depressive and Anxiety-Like Behaviors
Observed in Akt3 KO Mice
We next investigated whether the deletion of Akt3 in mice
could affect GSK3, a known direct downstream target of Akt.
Our western blot analysis revealed that levels of phosphorylated
GSK3α/β at serine 21/9 were significantly decreased in the
anterior cortex (unpaired t-test, GSK3α: p < 0.01; GSK3β:
p < 0.01), striatum (unpaired t-test, GSK3α: p < 0.001; GSK3β:
p < 0.01), hippocampus (unpaired t-test, GSK3α: p < 0.01;
GSK3β: p < 0.05) and cerebellum (unpaired t-test, GSK3α:
p < 0.01; GSK3β: p < 0.01) of Akt3 KO mice (Figure 5A). In
every Akt3 KO brain structures analyzed, no difference in levels
of total GSK3α/β was observed compared to WT mice.
To verify the effect of a chronic treatment on the depressive
and anxiety-like phenotypes observed in Akt3 KO mice, we used
the mood stabilizer lithium (Figure 5B). The serum lithium
concentrations were measured in mice at the end of treatments.
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FIGURE 5 | Chronic lithium treatment reversed depressive and anxiety-like behaviors in Akt3 KO mice. (A) Levels of phosphorylated GSK3α/β were
evaluated by western blot in the anterior cortex, striatum, hippocampus and cerebellum of Akt3 KO and WT mice. The data, expressed relative to total GSK3α/β,
represent the mean of relative optical density (expressed as a percentage of control values) ± SEM, n = 3 mice/group; triplicate experiments for each mouse/group.
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. WT mice. (B) Experimental design of chronic lithium treatment. (C) Depressive-like behavior was evaluated by the FST after
normal or lithium diet. Data express the mean time of immobility in seconds ± SEM, n = 6–12 mice/group. ∗∗p < 0.01, ∗∗∗p < 0.001 vs. WT fed with normal chow,
###p < 0.001 vs. Akt3 KO mice fed with normal chow. (D) Anxiety-like behavior was evaluated in the elevated plus maze after normal or lithium diet. Data are
expressed as the mean ± SEM, n = 10–12 mice/group. ∗p < 0.05 vs. WT fed with normal chow, #p < 0.05, ###p < 0.001 vs. Akt3 KO mice fed with normal chow.
Regardless of mice genotype, lithium concentration achieved
a mean of 0.089 ± 0.07 mM in mice fed with lithium chow,
whereas levels in mice fed with normal chow were undetectable.
In the FST, two-way ANOVA followed by the Bonferroni post
hoc test revealed that chronic lithium treatment significantly
decreased immobility time in Akt3 KO andWTmice (treatment,
F(1,19) = 76.67; p < 0.001; genotype, F(1,19) = 6.446; p < 0.05;
treatment× genotype, F(1,19) = 7.338; p< 0.05; Figure 5C). In the
elevated plusmaze, two-way ANOVA showed that Akt3 KOmice
treated with lithium spent more time in open arms (treatment,
F(1,34) = 0.2912; p > 0.05; genotype, F(1,34) = 1.240; p > 0.05;
treatment × genotype, F(1,34) = 6.129; p < 0.05) and entered
more frequently in the open arms compared to Akt3 KO fed
with normal chow (treatment, F(1,34) = 5.099; p< 0.05; genotype,
F(1,34) = 0.1706; p > 0.05; treatment × genotype, F(1,34) = 15.20;
p< 0.001; Figure 5D).
Chronic lithium treatment increased the levels of
phosphorylated GSK3α/β in the anterior cortex (unpaired
t-test, GSK3α: p < 0.01; GSK3β: p < 0.01), striatum (unpaired
t-test, GSK3α: p < 0.001; GSK3β: p < 0.001) and hippocampus
(unpaired t-test, GSK3α: p < 0.05; GSK3β: p < 0.01) of
Akt3 KO mice (Figures 6A–D). Only levels of phosphorylated
GSK3α were increased in the cerebellum (unpaired t-test,
GSK3α: p < 0.05; GSK3β: p > 0.05) of Akt3 KO mice. The
lithium treatment had no effect on the levels of total GSK3α/β
(Figures 6A–D).
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FIGURE 6 | Chronic lithium treatment increased the levels of phosphorylated GSK3α/β in Akt3 KO mice. At the end of the chronic lithium treatment, levels
of phosphorylated GSK3α/β were measured by western blot in the (A) anterior cortex, (B) striatum, (C) hippocampus and (D) cerebellum. The data, expressed
relative to total GSK3α/β level, represent the mean of relative optical density of phosphorylated GSK3α/β (expressed as a percentage of control values) ± SEM,
n = 4–8 mice/group for each condition; triplicate experiments for each mouse/group. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. WT fed with normal chow, #p < 0.05,
##p < 0.01, ###p < 0.001 vs. Akt3 KO mice fed with normal chow.
DISCUSSION
The specific function of Akt3 isoform in the brain is
poorly understood. Our study on Akt3 KO mice reports
that Akt3 deletion is associated with normal spatial learning
and memory as revealed by the Morris water maze and
novel object recognition tests. In addition, our results in
the rotarod, pole, wire and stepping tests provide evidence
that the Akt3 KO mice do not suffer from a generalized
deficit in locomotion, motor abilities and activity levels.
In fact, Akt3 deletion rather evokes changes in mouse
behavior reflecting psychiatric manifestations reminiscent of
schizophrenia, anxiety and depression. For instance, Akt3 KO
mice exhibited reduced prepulse inhibition and social novelty,
two phenotypes often seen in animal models of schizophrenia
(Nestler and Hyman, 2010). In particular, the prepulse inhibition
is disrupted in patients suffering from schizophrenia (Braff
et al., 2001) and asociality is considered to be one of
the most problematic symptoms of schizophrenia (Murphy
et al., 2006). Our results in two antidepressant-sensitive
tests, the force swim and TSTs, and three anxiogenic tests,
the open field, the elevated plus maze and the dark-light
tests, suggest that deletion of Akt3 increases susceptibility to
develop symptoms related to depression and anxiety. Altogether,
these comprehensive behavioral manifestations propose that
Akt3 signaling contributes to the normal functioning of the
neural circuitry intervening in the symptoms associated with
schizophrenia, depression and anxiety.
Systematic behavioral studies have never been performed
on the Akt3 KO mice before. However, it is established
that these mice have a reduction in brain weight resulting
from a decline in both cell size and number, but preserve
normal glucose homeostasis and body weights (Easton et al.,
2005; Tschopp et al., 2005). Based on these observations, it
is believed that Akt3 could be an important regulator of
postnatal brain development (Tschopp et al., 2005). Interestingly,
mood disorders such as schizophrenia and major depression
showed common and distinct patterns of volumetric alteration
relative to healthy individuals in a number of brain areas
(Wright et al., 2000; van Tol et al., 2010; Balevich et al.,
2015; Wise et al., 2016). The possibility that the observed
psychiatric-like behaviors may originate from the reduced
brain volume induced by Akt3 deletion is interesting, but
highly speculative. A small number of clinical studies suggest
that a copy number variation at the Akt3 locus could be
associated with abnormal brain size. For instance, individuals
with Akt3 deletions show microcephaly (Boland et al., 2007),
while duplications or gain-of-function Akt3 mutations are
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associated with megalencephaly (Rivière et al., 2012; Wang
et al., 2013; Nellist et al., 2015) and focal cortical dysplasia
(Chung et al., 2014). Whether Akt3 is the only responsible
gene for these witnessed clinical phenotypes is unclear. Further
investigations are definitively required in order to untangle
the putative brain consequence of impaired Akt3 activity. It
is becoming apparent, however, that Akt3 plays a critical
role in brain development and psychiatric manifestations in
mice.
While the link between deletion of Akt3 isoform and
psychiatric behaviors has never been established before, impaired
Akt activity was previously suspected in psychiatric conditions.
For example, post mortem tissue samples from patients with
schizophrenia showed significant reductions of phosphorylated
Akt levels in hilar neurons of the dentate gyrus and the
neurogenic zone of the hippocampus (Balu et al., 2012). Akt
activity is decreased in some brain regions (occipital cortex
and ventral prefrontal cortex) of depressed patients (Hsiung
et al., 2003; Karege et al., 2007). Phosphorylated Akt levels
in the ventral tegmental area are markedly decreased in mice
subjected to a depression model induced by stress, an effect
reversed by fluoxetine (Krishnan et al., 2008). The study of
normal physiological functions of each Akt isoform in the adult
brain has been made possible recently by the generation of
KO mouse models. Basic behavioral profiling of Akt1 KO mice
showed that there are no overall motor, anxiety and widespread
cognitive behavioral deficits, although displaying abnormal
working memory involving the hippocampus (Lai et al., 2006;
Balu et al., 2012). On the other hand, Akt2-deficient mice
exhibit normal growth, but develop a diabetes-like syndrome
with elevated fasting plasma glucose levels, elevated hepatic
glucose output, and peripheral insulin resistance (Cho et al.,
2001; Garofalo et al., 2003). Lately, Akt2 deletion has been
associated with anxiety and depressive-like behaviors (Leibrock
et al., 2013). Our data in Akt3 KO mice, showing preserved
normal glucose homeostasis and body weights (Easton et al.,
2005; Tschopp et al., 2005), demonstrate an endophenotype
reminiscent of schizophrenia, depression and anxiety. A more
methodical behavioral study using all three KO mice is
definitively required in order to further understand the specific
role of each isoform. It is still remarkable to note that the
three Akt isoforms do not exhibit identical functions. Another
evidence for this contention is the fact that these KO mice
studies demonstrate no compensatory upregulation of the
remaining isoforms (assessed at the mRNA or protein levels).
Correspondingly, our study reveals no effect of Akt3 deletion
on the protein levels of Akt1 and Akt2 in the anterior
cortex, striatum, hippocampus and cerebellum of Akt3 KO
mice.
Our behavioral and electrophysiological observations on
Akt3 KO mice suggest that Akt3 signaling may not play such
an important role in hippocampal related functions. To begin
with, normal spatial navigation and recognition memory are
revealed in these mice using two independent tests, the Morris
water maze and the object recognition. Many studies have
highlighted the implication of the hippocampus as a part of
the brain responsible for spatial navigation and recognition
memory (Broadbent et al., 2004; Vann and Albasser, 2011). It
is therefore interesting that electrophysiological measurements
achieved in the hippocampal area CA1 of Akt3 KO mice
are comparable to WT mice; which correlate nicely to
the behavioral data. Since Akt3 KO mice exhibit normal
performances at the Morris water maze, in the novel object
recognition test and in four motor abilities tests, we believe
that other brain functions, like motricity and motivation, are
unaltered in Akt3 KO mice. This additional evidence further
underscores the existence of a brain regional specificity of
Akt3 function. Levels of phosphorylated GSK3, a known direct
Akt molecular target, are robustly decreased in the hippocampus
of Akt3 KO mice. Lower levels of GSK3 phosphorylation
is well known to lead to enhanced GSK3 kinase activity
and signaling (Freland and Beaulieu, 2012). A previous study
performed in knockin mice with serine-to-alanine mutations of
GSK3α/β, to block inhibitory serine-phosphorylation, confirms
our results (Polter et al., 2010). These GSK3 knockin mice
display increased susceptibility to stress-induced depressive-like
behaviors, whereas normal electrophysiological recording from
the hippocampal area CA1 is shown. Altogether, these results
suggest that while Akt3 deletion is associated with an
endophenotype reminiscent of schizophrenia, anxiety and
depression, the Akt3/GSK3 signaling has no influence in
hippocampal area CA1 functions.
Akt3 deletion decreases GSK3α phosphorylation at serine
21 and GSK3β at serine 9 in every brain structure analyzed in
Akt3 KO mice, suggesting that the observed phenotype could be
a consequence of altered GSK3α/β phosphorylation. Since Akt
can modulate over a hundred of known substrates (Manning and
Cantley, 2007), we cannot exclude that the observed phenotype
in Akt3 KO mice may be associated with other signaling
pathways. Nevertheless, impaired GSK3α/β activity has been
previously recognized to play a role in psychiatric conditions
(Li and Jope, 2010). For instance, previous publications
have shown that anxiety and depressive-like behaviors are
associated with decreased brain levels of phosphorylated
GSK3α/β (Polter et al., 2010; Beurel et al., 2011). Notably,
in our experiments, the chronic lithium treatment known to
amplified GSK3α phosphorylation at serine 21 and GSK3β
at serine 9 (Mines et al., 2010; Liu et al., 2011), is able
to reverse the behavioral signs of anxiety and depression
observed in Akt3 KO mice. Besides, we observe that lithium is
returning back to control value the decreased phosphorylated
levels of GSK3α/β in the Akt3 KO mice. Since lithium
plasma concentrations measured were within the therapeutic
range (0.4–1.2 mEq/L) and no relevant adverse effects were
observed in mice fed with lithium (Malhi and Tanious,
2011), we believe the administered doses of lithium are
clinically relevant in our experimentations. The mechanism
by which lithium amplified GSK3α/β phosphorylation in
Akt3 KO mice was unfortunately not assessed by our study.
Lithium is a competitive inhibitor of magnesium and can
directly inhibit Mg2+-ATP-dependent catalytic activity of GSK3.
Alternatively, indirect GSK3 inhibition can be induced through
the inhibition of the protein phosphatase-2A or by increasing
Akt activity (Pan et al., 2011; Freland and Beaulieu, 2012).
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In that regards, it was demonstrated that Akt1 isoform is
essential for lithium to modulate mood-related behaviors in
mice (Pan et al., 2011). Protein levels of Akt1 are not
affected in the Akt3 KO mice but it is still possible that
the observed amplified GSK3α/β phosphorylation is caused
by an elevation of Akt1 activity. Additional biochemical
experiments are definitively required to confirm this hypothesis.
However, our data suggests that mechanisms underlying the
lithium therapeutic effects are intact in Akt3 KO mice.
They also confirm the implication of Akt3/GSK3α/β pathway
in the depressive and anxiety-like behaviors seen in these
mice.
It is noteworthy that recent human genetic studies are
in accord with our data and suggest that impaired Akt3 is
associated with schizophrenia, depression and anxiety
endophenotypes. In particular, Akt1 was originally identified
as a potential schizophrenia susceptibility gene (Emamian
et al., 2004). However, a recent multi-stage schizophrenia
genome-wide association study of up to 36,989 cases and
113,075 controls did not reproduce this finding (Schizophrenia
Working Group of the Psychiatric Genomics Consortium,
2014). They reported instead that only Akt3 represents
a potential contributor to schizophrenia with a high risk
factor of 64 out of 108 conservatively defined loci that meet
genome-wide significance. Another argument is the fact
that FXR1P, a direct molecular substrate of GSK3, has also
been identified as a high schizophrenia risk factor (26/108)
in this study. Notably, the study establishing FXR1P as a
GSK3 substrate has also demonstrated the importance of
these proteins interaction in the regulation of mood and
emotion processing (Del’Guidice et al., 2015). Altogether, our
data paired with these recent evidences raise the interesting
possibility that Akt3 might play a pivotal role in human
brain pathologies such as schizophrenia, depression and
anxiety.
In conclusion, modeling of human neuropsychiatric disorders
in rodents is extremely challenging. Progress in understanding
key molecular target in order to develop new therapeutics would
certainly benefit to this research field. Therefore, the involvement
of the Akt3 isoform in mice behaviors related to schizophrenia
and mood disorders is novel and highly relevant. We believe
that further investigation on the Akt3 isoform could lead to
a better understanding of the molecular basis implicated in
neuropsychiatric diseases.
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